TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmaq AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,639,976
|
1,255,516
|
1,122,465 |
Financial expenses |
84,593
|
80
|
1,392 |
Earnings before taxes |
816,837
|
557,842
|
584,172 |
Total assets |
2,997,071
|
2,204,192
|
1,669,561 |
Current assets |
2,548,868
|
1,691,866
|
1,238,103 |
Current liabilities |
412,904
|
283,817
|
276,379 |
Equity capital |
2,583,233
|
1,910,356
|
1,378,288 |
- share capital |
18,149
|
17,603
|
16,387 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.2%
|
86.7%
|
82.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
49.8%
|
44.4%
|
52.0% |
Return on assets (ROA) |
30.1%
|
25.3%
|
35.1% |
Current ratio |
617.3%
|
596.1%
|
448.0% |
Return on equity (ROE) |
31.6%
|
29.2%
|
42.4% |
Change turnover |
345,557
|
49,744
|
68,966 |
Change turnover % |
27%
|
4%
|
7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.